Michael D. Moeller

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel.

Part of Integra LifeSciences Holdings Corp., CardioDyne, Inc. develops blood pressure monitoring products. The company is based in Lake Forest, CA. CardioDyne was acquired by Primesource Healthcare, Inc. on October 25, 1995.

Part of Medtronic Plc, Vertelink Corp. is a company that develops materials and systems for spinal fixation devices. The company is based in Irvine, CA. The company was founded by Samuel M. Shaolian. Vertelink was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on December 03, 2003 for $22 million.

MiCardia Corp. designs, develops, and commercializes implantable medical devices. The firm offers implantable devices for the treatment of heart diseases, such as mitral valve regurgitation and congestive heart failure. It also provides enCor, an annuloplasty device that corrects residual mitral regurgitation on a beating heart. The company was founded in November 2004 by Michael R. Henson, Shawn Moaddeb and Samuel M. Shaolian and is headquartered in Irvine, CA.

Specialty Renal Products, Inc. develops medical devices for patients with renal diseases. The firm focuses on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End Stage Renal Disease (ESRD). The company was founded in 2018 and is headquartered in Nashville, TN.

Sophono, Inc. manufactures and distributes bone conduction hearing devices. The firm specializes in the development of the Alpha System, an abutment-free, implantable, and bone-anchored hearing system designed for individuals suffering from severe to profound hearing loss or impairment. It focuses on leveraging a surgical procedure with a third- generation sound processor to offer a system for hearing professionals and their patients. The company was founded by Markus Haller in October 2009 and is headquartered in Boulder, CO.

Wechsler & Co., Inc. operates as an investment company. The company is based in Mount Kisco, NY.

Wexford Capital LP (Wexford) is an independent, SEC-registered investment advisor headquartered in West Palm Beach, Florida with additional office in Stamford, Connecticut. The firm was founded by Charles Davidson, Joseph Jacobs and Robert Holtz in 1994. Wexford provides investment advice to a variety of private pooled investment vehicles over which the firm has discretionary trading authority.

Microbiogen Pty Ltd. develops non-genetically modified yeast. It develop non-genetically modified yeast to generate yeast strains for industrial purposes, which are used for ethanol production, high quality animal feed, baking, yeast extracts, enzymes, antioxidants, and waste stream management amongst others. The company is headquartered in Lane Cove, Australia.

Part of Medtronic Plc, Vascular Medcure, Inc. develops endovascular devices for optimal extraction. The company is based in Anaheim, CA. The company was founded in 2015 by Duy Nguyen, Thanh Nguyen. Samuel M. Shaolian has been the CEO of the company since 2018.

ApiFix Ltd. engages in the development of invasive scoliosis deformity correction systems for adolescent idiopathic scoliosis. The company was founded by Yizhar Floman and Uri Arnin in 2011 and is headquartered in Misgav, Israel.

Vascular Dynamics, Inc. provides blood pressure modulation devices. It develops and commercializes a passive, catheter-delivered implant for the treatment of hypertension. The company was founded in 2008 and is headquartered in Mountain View, CA.

Part of Globus Medical, Inc., NuVasive Specialized Orthopedics, Inc. develops and manufactures remote controlled implants. The company is based in San Diego, CA.

Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Embrella Cardiovascular, Inc. develops proprietary systems for embolic cerebral protection during cardiovascular procedures. The company was founded by Judith T. Carpenter and Jeffrey Francis O'Donnell, Sr. in 2007 and is headquartered in Wayne, PA.

Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA.

Part of Imagyn Medical Technologies, Inc., Microsurge, Inc. is a company that manufactures medical devices. The company is based in Needham, MA. The company was founded by E. James Hutchens. Microsurge was acquired by Urohealth Systems, Inc. on March 13, 1997 for $29 million.

ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. The company also develops Raindrop Near Vision Corneal Inlay, which is a refractive surgery solution. ReVision Optics was founded by Hansen A. Yuan, Adrian Koppes and Alok Nigam in 1996 and is headquartered Lake Forest, CA.

Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Cerebrotech Medical Systems, Inc. develops a technology for non-invasive monitor for early detection of cerebral events that can be catastrophic for patients after stroke, traumatic brain injury, brain surgery and other conditions. The company was founded by Mitchell E. Levinson in 2010 and is headquartered in Pleasanton, CA.